Tumor progression in the human melanocytic system
- PMID: 2554787
Tumor progression in the human melanocytic system
Abstract
The isolation and routine tissue culture of melanocytic cells from normal skin, precursor nevi, primary and metastatic melanomas has allowed the experimental study of different stages of tumor progression. Characteristic differences between cultured normal melanocytes and highly malignant metastatic melanoma cells were: 1) limited life span for normal melanocytes and non-malignant nevus cells versus infinite growth for malignant melanoma cells; 2) inability to grow anchorage-independently versus high colony forming-efficiency in soft agar; 3) non-tumorigenicity versus tumorigenicity in athymic nude mice; 4) dependence on exogenous growth factors and other mitogens versus autonomous growth in protein-free medium; 5) expression of melanocyte-associated antigens versus expression of melanoma-associated antigens; and 6) diploid karyotype versus non-random chromosomal abnormalities. The only major distinction found between advanced primary and metastatic melanomas was that only metastatic melanoma cells proliferated continuously in the absence of growth factors or other proteins. However, advanced primary melanoma cells could be clearly distinguished from dysplastic nevus cells by their growth behavior and growth factor requirements. Only limited information is available on the biologic, genetic, immunologic and molecular properties of dysplastic nevus cells and early (radial growth phase) primary melanoma cells but these cells appear to differ markedly from advanced primary and metastatic cells. The availability of cells from sequential steps of tumor progression in the human melanocytic system offers a unique experimental model for the study of malignant transformation.
Similar articles
-
Characteristics of cultured human melanocytes isolated from different stages of tumor progression.Cancer Res. 1985 Nov;45(11 Pt 2):5670-6. Cancer Res. 1985. PMID: 4053039
-
Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.Cancer Res. 1989 Sep 15;49(18):5091-6. Cancer Res. 1989. PMID: 2548711
-
Biology of tumor progression in human melanocytes.Lab Invest. 1987 May;56(5):461-74. Lab Invest. 1987. PMID: 3553733 Review.
-
Tumor progression in melanoma: the biology of epidermal melanocytes in vitro.Carcinog Compr Surv. 1989;11:369-86. Carcinog Compr Surv. 1989. PMID: 2646021 Review.
-
The initial steps of tumor progression in melanocytic lineage: a histochemical approach.Anticancer Res. 1991 Jul-Aug;11(4):1405-14. Anticancer Res. 1991. PMID: 1746897
Cited by
-
Molecular biology of testicular germ cell tumors: current status.J Mol Med (Berl). 1995 Jul;73(7):355-67. doi: 10.1007/BF00192887. J Mol Med (Berl). 1995. PMID: 8520968 Review. No abstract available.
-
Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma.Crit Rev Oncol Hematol. 2002 Oct;44(1):1-15. doi: 10.1016/s1040-8428(01)00196-2. Crit Rev Oncol Hematol. 2002. PMID: 12398996 Free PMC article. Review.
-
Human melanoma: development and progression.Cancer Metastasis Rev. 1990 Sep;9(2):101-12. doi: 10.1007/BF00046337. Cancer Metastasis Rev. 1990. PMID: 2253310 Review.
-
Differences in the known cellular composition of benign pigmented skin lesions reflected in computer-aided image analysis.Ann Dermatol. 2014 Jun;26(3):314-20. doi: 10.5021/ad.2014.26.3.314. Epub 2014 Jun 12. Ann Dermatol. 2014. PMID: 24966630 Free PMC article.
-
Ornidazole suppresses CD133+ melanoma stem cells via inhibiting hedgehog signaling pathway and inducing multiple death pathways in a mouse model.Croat Med J. 2022 Oct 31;63(5):461-474. doi: 10.3325/cmj.2022.63.461. Croat Med J. 2022. PMID: 36325671 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical